No Data
No Data
Express News | The biological product sector rose underwater, with Wantai Biological Pharmacy Enterprise surging nearly 4%, followed by Junshi Bio, Zhixiang Jintai, Kainos Technologies, Jiangsu Aidea Pharmaceutical, Remegen, Changchun High-Tech Industries and others.
Kain Technology (688687.SH) will distribute 2.5 yuan for every 10 shares in 2023. The stock registration date is May 21
Zhitong Finance App News, Kain Technology (688687.SH) announced that the company will implement the 2023 equity distribution and distribute a cash dividend of 2.5 yuan (tax included) for every 10 shares to all shareholders. The share registration date is May 21.
Kain Technology (688687) In-depth Report: Kailiwei, a new hepatitis C drug, is expected to create a second growth curve by selling probiotics derived from the new hepatitis B drug currently being developed by China and China
Hepatitis C: With the support of national policies, the diagnosis and treatment rate is expected to increase rapidly. Judging from the number of hepatitis C patients in China after expanding medical insurance indications, according to Polaris data, it is estimated that 9 people were infected with HCV in China in 2020
Kain Technology (688687.SH): Zhuoshangwan enquiry to transfer 2.34% of shares at a transfer price of 29.57 yuan/share
Kain Technology (688687.SH) announced that the price of the company's current inquiry and transfer is 29.57 yuan/share, and the number of shares transferred is 4 million shares. The actual number of transfers accounted for 2.34% of the total share capital. Zhuoshangwan participated in this inquiry transfer. Zhuoshangwan is a shareholding platform for the company's employees. It is a co-actor of the company's controlling shareholders and actual controllers, and some of the company's directors, supervisors and senior management indirectly hold shares in Kain Technology through the above employee shareholding platform.
Kain Technology (688687.SH): This inquiry was transferred to 29.57 yuan/share
Gelonghui, May 7, 丨 Kain Technology (688687.SH) announced that according to the inquiry and subscription situation on May 7, 2024, the initial price of Kain Technology's shareholder inquiry transfer (hereinafter referred to as “this inquiry transfer”) was 29.57 yuan/share, which is 93.52% of the closing price of 31.62 yuan/share on this inquiry transfer pricing date (that is, May 6, 2024). The shares to be transferred have been fully subscribed.
Express News | Science and Technology Innovation Board Review: The Science and Technology Innovation 50 Index closed down 1.01%, and aerospace concept stocks surged
No Data